Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405–14

James J. Hsieh, Mahtab Marker, David Chen

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e74-e75
JournalEuropean Urology
Volume72
Issue number3
DOIs
StatePublished - Sep 2017

Cite this